Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CD19 Protein, Human, Recombinant (His), AF488-Labeled

Catalog No. TMPY-07082

CD19 Protein, Human, Recombinant (His), AF488-Labeled is expressed in HEK293 Stable Cells. The accession number is P15391-1.

CD19 Protein, Human, Recombinant (His), AF488-Labeled

CD19 Protein, Human, Recombinant (His), AF488-Labeled

Catalog No. TMPY-07082
CD19 Protein, Human, Recombinant (His), AF488-Labeled is expressed in HEK293 Stable Cells. The accession number is P15391-1.
Pack SizePriceAvailabilityQuantity
Bulk & Custom
Add to Cart
Questions
View More
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Information

Biological Activity
Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description
CD19 Protein, Human, Recombinant (His), AF488-Labeled is expressed in HEK293 Stable Cells. The accession number is P15391-1.
Molecular Weight31.6 kDa (predicted)
Research Background
The cluster of differentiation (CD) system is commonly used as cell markers in Immunophenotyping. Different kinds of cells in the immune system can be identified through the surface CD molecules associating with the immune function of the cell. There are more than 320 CD unique clusters and subclusters have been identified. Some of the CD molecules serve as receptors or ligands important to the cell through initiating a signal cascade which then alter the behavior of the cell. Some CD proteins do not take part in cell signal process but have other functions such as cell adhesion. Cluster of differentiation 19 (CD19) is a member of CD system. CD19 is a cell surface molecule that assembles with the antigen receptor of B-cells. This results in a descent in the threshold for antigen receptor-dependent stimulation. A simplified view holds that the ability of B-cells to respond to the various antigens in a specific and sensitive manner is achieved in the presence of low-affinity antigen receptors. CD19 primarily acts as a B-cell co-receptor in conjunction with CD21 and CD81. The formation of the receptor complex is induced by antigen and CD19, induced by exogenous antigen, has been found cytoplasmic tail phosphorylated and bind to sIg.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy

Dose Conversion

You can also refer to dose conversion for different animals. More

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Tech Support

Please read the User Guide of Recombinant Proteins for more specific information.